Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|5|581-587

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.5, 2018-03, pp. : 581-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Chronic, Refractory Cough with Baclofen

By  

Respiration, Vol. 65, Iss. 1, 1998-02 ,pp. : 86-88

Karger

Access to resources Recommend Favorite

Pouchitis

By Schouten W. R.  

Mediators of Inflammation, Vol. 7, Iss. 3, 1998-06 ,pp. : 175-181

Informa Healthcare

Access to resources Recommend Favorite

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 4, 2015-04 ,pp. : 412-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 979-979

John Wiley & Sons Inc

Access to resources Recommend Favorite

TREATMENT OF CHRONIC SKIN ULCERS BY A PROTEOLYTIC ENZYME‐ANTIBIOTIC PREPARATION

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 15, Iss. 3, 1967-03 ,pp. : 219-223

John Wiley & Sons Inc

Access to resources Recommend Favorite